Market Cap

KPC Pharmaceuticals, Inc. Market Capitalization:

CN¥13.55 Billion

CNY as of July 1, 2024

US$1.86 Billion

business KPC Pharmaceuticals, Inc. Company Profile

KPC Pharmaceuticals, Inc. Main Stock Listing

SSE: 600422

Market Capitalization History of KPC Pharmaceuticals, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $80.13 B
MERCK Kommanditgesellschaft auf Aktien $71.24 B
Takeda Pharmaceutical Company Limited $41.23 B
Haleon plc $37.32 B
Teva Pharmaceutical Industries Limited $18.88 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of KPC Pharmaceuticals, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 CN¥15.80 B 27.40%
Jan. 1, 2023 CN¥12.41 B 68.69%
Jan. 1, 2022 CN¥7.35 B 13.83%
Jan. 1, 2021 CN¥6.46 B -24.62%
Jan. 1, 2020 CN¥8.57 B 80.39%
Jan. 1, 2019 CN¥4.75 B -30.05%
Jan. 1, 2018 CN¥6.79 B -31.57%
Jan. 1, 2017 CN¥9.93 B -6.56%
Jan. 1, 2016 CN¥10.62 B -1.08%
Jan. 1, 2015 CN¥10.74 B 27.53%
Jan. 1, 2014 CN¥8.42 B 0.37%
Jan. 1, 2013 CN¥8.39 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

KPC Pharmaceuticals, Inc. Categories

China languages Healthcare languages Drug Manufacturers—Specialty & Generic
China Healthcare China Drug Manufacturers—Specialty & Generic

Stocks & Indices

KPC Pharmaceuticals, Inc. has the following listings and related stock indices.


Stock: SSE: 600422

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.